BH3 Mimetics Help T Cells Kill Acute Myeloid Leukemia Cells
Author Information
Author(s): Yee Cassian, Saxena Kapil, Ryu Esther, Hung Shao-Hsi, Singh Shailbala, Zhang Qi, Zeng Zhihong, Wang Zhe, Konopleva Marina
Hypothesis
Strategies to lower the AML apoptotic threshold will augment T cell killing of AML cells.
Conclusion
The combination of BH3 mimetics and CD8+ T cells significantly increases the killing of acute myeloid leukemia cells.
Supporting Evidence
- The combination of BH3 mimetics and CD8+ T cells led to significantly increased killing of established AML lines.
- The approach was effective against adverse-risk primary AML leukemic blast cells.
- Killing was primarily through activation of the intrinsic/mitochondrial apoptotic pathway.
Takeaway
This study shows that using certain drugs can help T cells better kill leukemia cells, which could help patients with this type of cancer.
Methodology
The study explored the efficacy of BH3 mimetics combined with WT1-specific CD8+ T cells on AML cell lines and primary samples.
Participant Demographics
The study evaluated primary samples from patients with a diverse array of disease characteristics.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website